Disruptions in the Strait of Hormuz are threatening nearly a quarter of global oil flows, rattling markets and supply chains. Here are three scenarios that could decide how the world’s most critical energy chokepoint reopens.
Alembic Pharma gets USFDA nod for generic Dapagliflozin tablets, equivalent to AstraZenecas Farxiga, gaining 180 day shared exclusivity in a $10.49 billion US market
Brokerages expect Nykaa to deliver strong Q4 growth led by beauty and improving traction in fashion, with margins set to expand and losses narrowing, though views remain divided on valuations.
Manish Sonthalia, CIO of Emkay Investment Managers highlights opportunities in financials, defence, power and IT, while advising caution on travel and real estate amid cost pressures.
CreditAccess Grameen reported strong growth with higher disbursements, improvement in asset quality and branch expansion for the financial year 2026.
Gautam Duggad, Head of Research, Director – Institutional Equities at Motilal Oswal Financial Services noted that sectoral trends have led to a broader earnings downgrade of around 3% across his coverage universe of over 360 stocks. Within this, midcaps and…
Wall Street expects strong Q1 earnings led by tech despite US Iran war, oil price surge and valuations pose risks, energy profits may rise, investors hope conflict eases soon
Brokerage firm Jefferies expects this railway stock to be a key beneficiary of the increasing passenger and metro coach demand. The stock has corrected significantly from record high levels.
Rupee opens at 93 per dollar after RBI backed unwinding, stabilising from recent volatility, but remains vulnerable as Iran tensions lift Brent crude to about 111 per barrel
BofA said the recent correction in banking stocks appears overdone, with value emerging, particularly in large banks. It has turned more constructive on the segment, citing the current macro outlook and attractive valuations.